Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units

Methicillin-resistant Staphylococcus aureus (MRSA) causes severe morbidity and mortality in intensive care units (ICUs) worldwide. The purpose of this study was to determine whether intranasal mupirocin prophylaxis is useful to prevent ICU-acquired infections with MRSA. We conducted a 4-year observa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical care (London, England) England), 2005-06, Vol.9 (3), p.R246-R250, Article R246
Hauptverfasser:	Muller, Arno, Talon, Daniel, Potier, Alexandre, Belle, Evelyne, Cappelier, Gilles, Bertrand, Xavier
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intranasal Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Cross Infection - prevention & control Hospital Mortality Humans Intensive Care Units Length of Stay Methicillin Resistance Mupirocin - administration & dosage Mupirocin - therapeutic use Retrospective Studies Staphylococcal Infections - prevention & control Staphylococcus aureus - isolation & purification
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!